Clinical Trial Update: 11C-acetate for Treatment Response After Radiotherapy for HCC [Phase 2]

View source ↗

Summary

Phase 2 study evaluating 11C-acetate as an imaging biomarker to assess treatment response after radiotherapy in hepatocellular carcinoma was terminated, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 11C-Acetate (carbon-11 acetate)

Snippet

Sponsor: Justin Sims | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-11-22